1. Home
  2. BV vs EVO Comparison

BV vs EVO Comparison

Compare BV & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BV

BrightView Holdings Inc.

HOLD

Current Price

$12.78

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.56

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BV
EVO
Founded
1939
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BV
EVO
Price
$12.78
$3.56
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$14.63
$7.00
AVG Volume (30 Days)
558.7K
89.0K
Earning Date
02-03-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$2,688,300,000.00
$887,396,457.00
Revenue This Year
$3.86
N/A
Revenue Next Year
$2.70
$8.52
P/E Ratio
$175.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.06
$2.84
52 Week High
$17.11
$4.80

Technical Indicators

Market Signals
Indicator
BV
EVO
Relative Strength Index (RSI) 44.41 50.42
Support Level $12.37 $3.38
Resistance Level $13.94 $3.82
Average True Range (ATR) 0.36 0.09
MACD -0.06 -0.02
Stochastic Oscillator 27.48 38.64

Price Performance

Historical Comparison
BV
EVO

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: